Press release
Global Peptides and Heparin Market Poised for Rapid Surge at a CAGR of 8.10% by 2026
According to Fact.MR, the global peptide and heparin market is projected to reflect a high single-digit CAGR throughout the forecast period (2017-2026). The market is estimated to reach nearly US$ 35,000 Mn revenues by 2026-end.Request For Sample Report @https://www.factmr.com/connectus/sample?flag=S&rep_id=378
The scope of Fact.MR’s report is to analyze the global peptide and heparin market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global peptide and heparin market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to peptide and heparin.
Key Future Prospects of Peptide and Heparin Market for Forecast Period 2017-2026
1) Hospital pharmacies are expected to remain the dominant distribution channel for peptide and heparin. Revenues from sales of peptide and heparin in hospital pharmacies are anticipated to remain considerably larger than those from retail pharmacies and online pharmacies combined.
2) On the basis of indication, revenues from sales of peptide and heparin for cancer treatment are projected to account for the largest market share by 2026-end. Cardiovascular and metabolic disorder indication will also remain remunerative in the market. Sales of peptide and heparin for central nervous systems indication are expected to register the fastest expansion through 2026.
3) Oral route of administration will remain preferred for peptide and heparin, with revenues estimated to surpass US$ 15,000 Mn by 2026-end. However, sales of peptide and heparin with intravenous route of administration will register a comparatively faster growth through 2026.
4) Liraglutide is expected to remain the most lucrative product in the market, followed by bortezomib and goserelin. Liraglutide sales will exhibit the highest CAGR through 2026. In addition, sales of sodium heparin, lithium heparin and exenatide are projected to register a parallel growth through 2026.
5) Asia-Pacific excluding Japan (APEJ) will continue to be the largest market for peptide and heparin, in terms of revenues. The markets in Europe and North America will also remain lucrative, however revenues from these regions will remain significantly lower than those from APEJ.
Browse Full Report with TOC @https://www.factmr.com/report/378/peptides-heparin-market
APEJ to Remain Most Remunerative Market for Peptide and Heparin
There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ). Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region. In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.
Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.
Competition Tracking
The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors. These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas. Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future. Key market participants identified by the report include Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma, Teva, Takeda, Sanofi, Novo Nordisk, and Eli Lilly.
Check Discount @https://www.factmr.com/connectus/sample?flag=D&rep_id=378
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peptides and Heparin Market Poised for Rapid Surge at a CAGR of 8.10% by 2026 here
News-ID: 944370 • Views: …
More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between…

Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032.
Market Drivers & Outlook
The demand for…

Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems.
Key…

Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate…
More Releases for APEJ
APEJ to Spearhead the Global Soy Protein Hydrolysate by 2026
The Global Dietary Supplements Industry Current Scenario and Outlook
The unprecedented COVID-19 outbreak has brought significant challenges for various industries across the globe. Stringent restrictions on movement, production, supply of raw materials, and limited stocks have affected the growth of businesses to a great extent.However, with the roll out of the vaccination process in countries like the U.S., the U.K., China, India, and Germany, manufacturers are gaining momentum in terms of…
Lacquer Market : APEJ to be the largest market through 2028
Global demand for lacquers is likely to reach roughly 7 million tons in 2018, as applications in furniture, automotive, and architectural industries create sustained growth opportunities. The shift from solvent-based to water-based lacquers will become more palpable in the next decade, as a combination of environmental compliance and end-user consciousness induces changes in manufacturing and uptake. The long-term outlook on lacquer market remains bullish, with novel applications in cosmetics likely…
Dimethylolpropionic Acid (DMPA) Market: APEJ to Remain Largest Consuming
Future Market Insights (FMI) delivers key insights on the global dimethylolpropionic acid market in its upcoming report titled “Dimethylolpropionic Acid (DMPA) Market: Global Industry Analysis and Opportunity Assessment 2015–2020”. The global Dimethylolpropionic Acid (DMPA) market is projected to expand at a CAGR of over 8% during the forecast period (2015–2020), largely due to increasing demand for polyurethane dispersions, regarding which FMI offers vital insights in detail in this report.
On the…
Global Construction Polymer Manufacturing to Remain Concentred in the APEJ Regio …
Over the years, the global construction industry has emerged as the largest consumer of polymer composites. Surging use of polymer and polymer composite materials in the construction industry has been instrumented by the technical, structural, architectural, and designing advantages of construction polymers over conventional construction materials such as dust, sand and concrete.
Future Market Insights’ new report reveals that by the end of 2026, over US$ 135 Mn worth of…
APEJ Automotive Aftermarket to hit US$ 218.73 Bn by 2025
Future Market Insights (FMI) announces release of its latest market outlook forecast titled “Automotive Aftermarket: Asia-Pacific Excl. Japan (APEJ) Industry Analysis and Opportunity Assessment 2015 - 2025”. According to this report, automotive aftermarket components in Asia Pacific is anticipated to account for US$ 218.73 Bn by 2025, registering a compound annual growth rate (CAGR) of 9.1% throughout the forecast period.
The automotive aftermarket is a secondary market, which plays a…
APEJ Automotive Aftermarket Poised to hit US$ 218.73 Bn by 2025
Future Market Insights (FMI) announces release of its latest market outlook forecast titled “Automotive Aftermarket: Asia-Pacific Excl. Japan (APEJ) Industry Analysis and Opportunity Assessment 2015 - 2025”. According to this report, automotive aftermarket components in Asia Pacific is anticipated to account for US$ 218.73 Bn by 2025, registering a compound annual growth rate (CAGR) of 9.1% throughout the forecast period.
The automotive aftermarket is a secondary market, which plays a…